866-997-4948(US-Canada Toll Free)

Genomics Personalized Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Published By :

Transparency

Published Date : Jun 2017

Category :

Biotechnology

No. of Pages : 180 Pages

Global Genomics Personalized Health Market: Overview

This report on Genomics Personalized Health market studies the current as well as future forecasts of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacturing and commercialization of various Genomics Personalized Health instrument and products as well as new entrants planning to enter this market. This report covers an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global Genomics Personalized Health market with respect to the prominent market segments based on major technology, test type, end-user, and geographies. 

Global Genomics Personalized Health Market: Segmentation

The global Genomics Personalized Health market is divided into: by technology, by test type, by end-user and by geography. On the basis of technology the Genomics Personalized Health market is segmented as NGS platforms, RT-PCR, Microarray, Genetic analyzers, and. On the basis of test type Genomics Personal Health Market is segmented as oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. On the basis of end-user the Genomics Personalized Health market is classified as academics & research Institutes, diagnostic centers, and others. The market for the above mentioned segments of global personalized health market has been comprehensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn along with the compound annual growth rate (CAGR %) from 2017 to 2025 has been provided for all segments, considering 2016 as the base year. 

Global Genomics Personalized Health Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global Genomics Personalized Health market and can influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the global genomics personalized health market across different types of technologies/test type/end-users/geographies. The competitive scenario among different market players in global genomics personalized health market is evaluated through market share analysis in the competition landscape section of the report. The section also comprises of completion matrix that analyzes the competition among some of the top global players operating in the genomics personalized health market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. 

Global Genomics Personalized Health Market: Regional Outlook

Geographically, the Genomics Personalized Health market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for Genomics Personalized Health market has been further categorized into major technology, test type and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2015 to 2025 along with CAGR % from 2017 to 2025 are provided for all the regions and nations considering 2016 as the base year. 

Key Players Mentioned in this Report are:

The report profiles key manufacturers in the Genomics Personalized Health market based on various characteristics such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include QIAGEN, Illumina, Inc., Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc. ,F. Hoffmann-La Roche AG, Lonza Group, INVITAE Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.),uBiome, Inc., and XCode Life Sciences Private Limited. 

The global Genomics Personalized Health market has been segmented as follows:

Genomics Personalized Health Market, by Technology

  • NGS platforms
  • RT-PCR
  • Microarray
  • Sequencing and genetic analyzers
  • Others 

Genomics Personalized Health Market, by Test Type

  • Oncology testing
  • Infectious disease testing
  • Orphan disease testing
  • Autoimmune disease testing
  • Obstetrics testing
  • Others 

Genomics Personalized Health Market, By End-User

  • Academics & Research Institutes
  • Diagnostic Centers
  • Others

Genomics Personalized Health Market, by Geography 

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Content

Section - 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section - 2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Genomics Personalized Health: Market Snapshot
3.2 Global Genomics Personalized Health Market: Opportunity Map

Section-4 Market Overview
4.1 Global Genomics Personalized Health Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.3 Restraints
5.1.4 Opportunity Analysis
5.2 Key Trends
5.3 Porter’s Five Forces Analysis
5.4 Global Genomics Personalized Health Market Revenue Projection
5.5 Genomics Personalized Health Market Outlook

Section-6 Genomics Personalized Health Market Analysis by Technology
6.1 Key Findings
6.2 Introduction
6.3 Global Genomics Personalized Health Market Value Share Analysis, By Technology 
6.4 Global Genomics Personalized Health Market Forecast by Technology 
6.4.1 NGS Platform
6.4.2 RT-PCR
6.4.3 Microarray
6.4.4 Genetic Analyzers
6.4.5 Others
6.5 Global Genomics Personalized Health Market Attractiveness Analysis by Technology 
6.6 Key Insights

Section-7 Global Genomics Personalized Health Market Analysis by Test Type
7.1 Key Findings
7.2 Introduction
7.3 Global Genomics Personalized Health Market Value Share Analysis, By Test type
7.4 Global Genomics Personalized Health Market Forecast by Test type
7.4.1 Oncology Testing
7.4.2 Infectious Disease Testing
7.4.3 Orphan Disease Testing
7.4.4 Autoimmune Disease Testing
7.4.5 Obstetric Testing
7.4.6 Others
7.5 Global Genomics Personalized Health Market Attractiveness Analysis by Product
7.6 Key Insights 

Section-8 Global Genomics Personalized Health Market Analysis by End User
8.1 Key Findings
8.2 Introduction
8.3 Global Genomics Personalized Health Market Value Share Analysis, By End User
8.4 Global Genomics Personalized Health Market Forecast by End User
8.4.1 Academics & Research Institutes 
8.4.2 Diagnostic Centers
8.4.3 Others
8.5 Global Genomics Personalized Health Market Attractiveness Analysis by End User
8.6 Key Insights

Section-9 Global Genomics Personalized Health Market Analysis, By Region
9.1 Global Genomics Personalized Health Market Snapshot, by Country
9.2 Introduction
9.3 Global Genomics Personalized Health Market Forecast by Region
9.4 Global Genomics Personalized Health Market Attractiveness Analysis, By Region
9.5 Key Insights

Section-10 North America Genomics Personalized Health Market Analysis
10.1 North America Market Value Share Analysis, By Country
10.1.1 North America Market Forecast by Country
10.2 North America Market Forecast by Technology
10.3 North America Market Forecast by Test Type
10.4 North America Market Forecast by End User
10.5 North America Market Attractiveness Analysis
10.6 Key Trends

Section-11 Europe Genomics Personalized Health Market Analysis
11.1 Europe Market Value Share Analysis, By Country
11.1.1 Europe Market Forecast by Country
11.2 Europe Market Forecast by Technology
11.3 Europe Market Forecast by Test Type
11.4 Europe Market Forecast by End User
11.5 Europe Market Attractiveness Analysis
11.6 Key Trends

Section-12 Asia Pacific Genomics Personalized Health Market Analysis
12.1 Asia Pacific Market Value Share Analysis, By Country
12.1.1 Asia Pacific Market Forecast by Country
12.2 Asia Pacific Market Forecast by Technology
12.3 Asia Pacific Market Forecast by Test Type
12.4 Asia Pacific Market Forecast by End User
12.5 Asia Pacific Market Attractiveness Analysis
12.6  Key Trends

Section-13 Latin America Genomics Personalized Health Market Analysis
13.1 Latin America Market Value Share Analysis, By Country
13.1.1 Latin America Market Forecast by Country
13.2 Latin America Market Forecast by Technology 
13.3 Latin America Market Forecast by Test Type
13.4 Latin America Market Forecast by End User
13.5 Latin America Market Attractiveness Analysis
13.6 Key Trends

Section-14 Middle East and Africa Genomics Personalized Health Market Analysis
14.1 Middle East and Africa Market Value Share Analysis, By Country
14.1.1 Middle East and Africa Market Forecast by Country
14.2 Middle East and Africa Market Forecast by Technology
14.3 Middle East and Africa Market Forecast by Test Type
14.4 Middle East and Africa Market Forecast by End User
14.5 Middle East and Africa Market Attractiveness Analysis
14.6 Key Trends

Section-15 Competition Landscape
15.1. Global Genomics Personalized Health Market Share Analysis, by Company 
15.2. Competition Matrix
15.3 Company Profiles
15.3.1 QIAGEN
15.3.1.1. Company Details 
15.3.1.2. Market Presence, By Segment and Geography
15.3.1.3. Strategic Overview
15.3.1.4. SWOT analysis
15.3.1.5. Strategic Overview
15.3.2 Illumina, Inc. 
15.3.2.1. Company Details  
15.3.2.2. Market Presence, By Segment and Geography
15.3.2.3. Strategic Overview
15.3.2.4. SWOT analysis
15.3.2.5. Strategic Overview
15.3.3 Thermo Fisher Scientific, Inc. 
15.3.3.1. Company Details  
15.3.3.2. Market Presence, By Segment and Geography
15.3.3.3. Strategic Overview
15.3.3.4. SWOT analysis
15.3.3.5. Strategic Overview
15.3.4 Bio-Rad Laboratories, Inc. 
15.3.4.1. Company Details  
15.3.4.2. Market Presence, By Segment and Geography
15.3.4.3. Strategic Overview
15.3.4.4. SWOT analysis
15.3.4.5. Strategic Overview
15.3.5 F. Hoffmann-La Roche AG 
15.3.5.1. Company Details  
15.3.5.2. Market Presence, By Segment and Geography
15.3.5.3. Strategic Overview
15.3.5.4. SWOT analysis
15.3.5.5. Strategic Overview
15.3.6 Lonza Group 
15.3.6.1. Company Details  
15.3.6.2. Market Presence, By Segment and Geography
15.3.6.3. Strategic Overview
15.3.6.4. SWOT analysis
15.3.6.5. Strategic Overview
15.3.7 INVITAE Corporation
15.3.7.1. Company Details  
15.3.7.2. Market Presence, By Segment and Geography
15.3.7.3. Strategic Overview
15.3.7.4. SWOT analysis
15.3.7.5. Strategic Overview
15.3.8 Genetic Technologies Limited 
15.3.8.1. Company Details  
15.3.8.2. Market Presence, By Segment and Geography
15.3.8.3. Strategic Overview
15.3.8.4. SWOT analysis
15.3.8.5. Strategic Overview
15.3.9 Interleukin Genetics Inc.
15.3.9.1. Company Details  
15.3.9.2. Market Presence, By Segment and Geography
15.3.9.3. Strategic Overview
15.3.9.4. SWOT analysis
15.3.9.5. Strategic Overview
15.3.10 Eastern Biotech and Life Sciences 
15.3.10.1. Company Details  
15.3.10.2. Market Presence, By Segment and Geography
15.3.10.3. Strategic Overview
15.3.10.4. SWOT analysis
15.3.10.5. Strategic Overview
15.3.11 DNA Genotek Inc. (Subsidiary of OraSure Technologies, Inc.)
15.3.11.1. Company Details  
15.3.11.2. Market Presence, By Segment and Geography
15.3.11.3. Strategic Overview
15.3.11.4. SWOT analysis
15.3.11.5. Strategic Overview
15.3.12 uBiome, Inc.
15.3.12.1. Company Details  
15.3.12.2. Market Presence, By Segment and Geography
15.3.12.3. Strategic Overview
15.3.12.4. SWOT analysis
15.3.12.5. Strategic Overview
15.3.13 XCode Life Sciences Private Limited 
15.3.13.1. Company Details 
15.3.13.2. Market Presence, By Segment and Geography
15.3.13.3. Strategic Overview
15.3.13.4. SWOT analysis
15.3.13.5. Strategic Overview

List of Table

Table 01: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Technology,     2015–2025
Table 02: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type,     2015–2025
Table 03: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user,     2015–2025
Table 04: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Region,     2015–2025
Table 05: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 06: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 07: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 08: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 09: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by Technology,     2015–2025
Table 10: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test Type,     2015–2025
Table 11: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-user,     2015–2025
Table 12: Europe Genomic Personalized Health Market Size (US$ Mn) Forecast, by 
Table 13: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 14: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 15: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 16: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 17: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology, 2015–2025
Table 18: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by Test     Type, 2015–2025
Table 19: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by End-    user, 2015–2025
Table 20: Latin America Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025
Table 21: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Technology Type, 2017–2025
Table 22: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Test Type, 2015–2025
Table 23: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     End User, 2015–2025
Table 24: Middle East & Africa Genomic Personalized Health Market Size (US$ Mn) Forecast, by     Country, 2015–2025

List of Chart

Figure 1: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Market Value Share, by Technology (2017)
Figure 3: Market Value Share, by Test Type (2017)
Figure 5: Market Value Share, by Region (2017)
Figure 4: Market Value Share, by End-user (2017)
Figure 6: Global Genomics Personalized Health Market Value Share Analysis, by Technology, 2016 and 2025
Figure 7: Global Genomics Personalized Health Market Attractiveness Analysis, by Technology, 2017–2025
Figure 9: Global RT-PCR Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 8: Global NGS Platform Market Revenue (US$ Mn) and
Figure 11: Global Genetic Analyzer Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast,     2015–2025
Figure 10: Global Microarray Market Revenue (US$ Mn) and
Figure 12: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 13: Global Genomics Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 14: Global Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 15: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology Testing, 2015–2025
Figure 16: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease Testing, 2015–2025
Figure 17: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Orphan Disease Testing, 2015–2025
Figure 18: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Autoimmune Disease Testing, 2015-2025
Figure 19: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), By Obstetric Testing, 2015–2025
Figure 20: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), BY Other Testing, 2015-2025
Figure 21: Global Genomics Personalized Health Market Value Share Analysis, by End-user, 2017 and 2025
Figure 22: Global Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2017–2025
Figure 23: Global Academic & Research Institutes Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Global Diagnostic Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Genomics Personalized Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 26: Global Genomics Personalized Health Market Value Share Analysis, by Region, 2017     and 2025
Figure 27: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2017–2025
Figure 28: North America Genomic Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 29: North America Genomic Personalized Health Market Attractiveness Analysis, by Country
Figure 30: North America Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 31: North America Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 32: North America Market Value Share Analysis, by End-user, 2017 and 2025
Figure 33: North America Market Value Share Analysis, by Country, 2017 and 2025
Figure 34: North America Market Attractiveness Analysis, by Technology
Figure 35: North America Market Attractiveness Analysis, by Test Type
Figure 36: North America Market Attractiveness Analysis, by End-user
Figure 37: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 38: Europe Genomics Personalized Health Market Size, Y-o-Y Growth Projections, 2016–2025
Figure 39: Europe Genomics Personalized Health Market Attractiveness Analysis, by Country, 2017–2025
Figure 40: Europe Genomics Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 41: Europe Genomics Personalized Health Market Value Share Analysis, by Test Type17 and 2025
Figure 42: Europe Genomics Personalized Health Market Value Share Analysis, by End-user, 2017 and 2025
Figure 43: Europe Genomic Personalized Health Market Value Share Analysis, by Country / Sub-    region, 2017 and 2025
Figure 44: Europe Genomic Personalized Health Market Attractiveness Analysis, by Technology
Figure 45: Europe Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 46: Europe Genomic Personalized Health Market Attractiveness Analysis, by End-user
Figure 47: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast,
Figure 48: Asia Pacific Genomics Personalized Health Market Y-o-Y Growth (%) Projections, 2016–2025
Figure 49: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by     Country, 2017–2025
Figure 50: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 51: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 52: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by End-    user, 2017 and 2025
Figure 53: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 54: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Technology
Figure 55: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Test Type
Figure 56: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by End-    user
Figure 57: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, 2015–2025
Figure 58: Latin America Genomics Personalized Health Market Y-o-Y Growth (%) Projections, 2016–2025
Figure 59: Latin America Genomic Personalized Health Market Attractiveness Analysis, by     Country
Figure 60: Latin America Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 61: Latin America Genomic Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 62: Latin America Genomic Personalized Health Market Value Share Analysis, by End-    user, 2017 and 2025
Figure 63: Latin America Genomic Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 64: Latin America Genomic Personalized Health Market Attractiveness Analysis, by Technology
Figure 65: Latin America Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 66: Latin America Genomic Personalized Health Market Attractiveness Analysis, by End- user, 2017-2025
Figure 67: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast,2015–2025
Figure 68: Middle East & Africa Genomics Personalized Health Market Y-o-Y Growth (%)     Projections, 2016–2025
Figure 69: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by     Country
Figure 70: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Technology, 2017 and 2025
Figure 71: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Test Type, 2017 and 2025
Figure 72: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by End User, 2017 and 2025
Figure 73: Middle East & Africa Genomic Personalized Health Market Value Share Analysis, by Country, 2017 and 2025
Figure 74: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by Technology Type 
Figure 75: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, by Test Type
Figure 76: Middle East & Africa Genomic Personalized Health Market Attractiveness Analysis, byEnd User
Figure 77: Global Genomic Personal Health Market Share Analysis, by Company (2016)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *